Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: GuinnessGuy who wrote (232)	1/13/1998 9:06:00 PM
From: Ian@SI	Read Replies (1) \| Respond to of 1321

Craig, Sounds like Geron has a dream which may or may not come to pass. Hopefully, it will. QLT has an approved drug being used for a variety of treatments globally; and a Phase III trial underway for AMD (completes this year). From what I've seen so far, Geron won't have a competitive drug approved in less than 3 years, if ever. JMHO, Ian.

To: GuinnessGuy who wrote (232)	1/13/1998 9:11:00 PM
From: Michael Anthony	Respond to of 1321

Very interesting. Interesting enough for a 45% pop in GERN's price! I will certainly look into it. To bad it's today instead of yesterday :( The science makes sense, but you never know about these things until they undergo scientific scrutiny....then there's FDA approval. I only glanced, but I don't think they are much more along than proving they have a good idea. Making it pay off is another long hurdle to get through. Probably a long time before they make any money, but it could be one to accumulate. Thanks for the tip.